American Century Companies’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-173,084
| Closed | -$16.1M | – | 2386 |
|
|
2021
Q4 | $16.1M | Buy |
173,084
+38,672
| +29% | +$2.55M | 0.01% | 751 |
|
|
2021
Q3 | $8M | Buy |
134,412
+572
| +0.4% | +$33.8K | 0.01% | 907 |
|
|
2021
Q2 | $9.13M | Buy |
133,840
+8,305
| +7% | +$541K | 0.01% | 845 |
|
|
2021
Q1 | $8.71M | Sell |
125,535
-678
| -0.5% | -$52.2K | 0.01% | 805 |
|
|
2020
Q4 | $9.7M | Sell |
126,213
-24,778
| -16% | -$1.86M | 0.01% | 767 |
|
|
2020
Q3 | $11.3M | Sell |
150,991
-56,267
| -27% | -$3.75M | 0.01% | 686 |
|
|
2020
Q2 | $13M | Sell |
207,258
-56,675
| -21% | -$3.12M | 0.01% | 612 |
|
|
2020
Q1 | $11.1M | Buy |
263,933
+15,363
| +6% | +$704K | 0.01% | 576 |
|
|
2019
Q4 | $11.3M | Buy |
248,570
+26,441
| +12% | +$1.25M | 0.01% | 651 |
|
|
2019
Q3 | $10.2M | Buy |
222,129
+10,561
| +5% | +$594K | 0.01% | 608 |
|
|
2019
Q2 | $12.4M | Buy |
211,568
+83,163
| +65% | +$4.3M | 0.01% | 586 |
|
|
2019
Q1 | $5.76M | Sell |
128,405
-2,292
| -2% | -$105K | 0.01% | 772 |
|
|
2018
Q4 | $5.09M | Sell |
130,697
-1,471
| -1% | -$57.8K | 0.01% | 802 |
|
|
2018
Q3 | $6.08M | Buy |
132,168
+24,741
| +23% | +$1M | 0.01% | 816 |
|
|
2018
Q2 | $4.68M | Sell |
107,427
-644
| -0.6% | -$27.7K | ﹤0.01% | 862 |
|
|
2018
Q1 | $4.27M | Buy |
108,071
+17,969
| +20% | +$699K | ﹤0.01% | 864 |
|
|
2017
Q4 | $3.06M | Buy |
90,102
+25,108
| +39% | +$715K | ﹤0.01% | 933 |
|
|
2017
Q3 | $1.66M | Buy |
64,994
+41,082
| +172% | +$942K | ﹤0.01% | 1063 |
|
|
2017
Q2 | $403K | Buy |
+23,912
| New | +$328K | ﹤0.01% | 1254 |
|
|
2015
Q1 | – | Sell |
-20,519
| Closed | -$712K | – | 1463 |
|
|
2014
Q4 | $712K | Buy |
20,519
+1,196
| +6% | +$48.6K | ﹤0.01% | 1236 |
|
|
2014
Q3 | $810K | Buy |
19,323
+1,419
| +8% | +$63.4K | ﹤0.01% | 1219 |
|
|
2014
Q2 | $1.05M | Buy |
17,904
+3,937
| +28% | +$248K | ﹤0.01% | 1207 |
|
|
2014
Q1 | $880K | Sell |
13,967
-34,087
| -71% | -$2.26M | ﹤0.01% | 1250 |
|
|
2013
Q4 | $2.81M | Sell |
48,054
-52
| -0.1% | -$2.72K | ﹤0.01% | 1049 |
|
|
2013
Q3 | $2.54M | Buy |
48,106
+30,789
| +178% | +$2.07M | ﹤0.01% | 1065 |
|
|
2013
Q2 | $1.33M | Buy |
+17,317
| New | +$1.41M | ﹤0.01% | 1161 |
|
American Century Companies's ARNA Position: Q1 2022 in Review
American Century Companies sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 173,084 shares — an estimated $16.1M sold.
American Century Companies first reported a position in ARNA in Q2 2013 and held it in 26 quarters. The position peaked at $16.1M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- American Century Companies reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- American Century Companies sold 173,084 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $16.1M.
- American Century Companies first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 26 quarters.
- American Century Companies's Arena Pharmaceuticals Inc position peaked at $16.1M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on American Century Companies's 13F filing for Q1 2022, filed 11 May 2022.